Department of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.
J Am Chem Soc. 2012 Aug 29;134(34):13997-4003. doi: 10.1021/ja3036114. Epub 2012 Aug 16.
Silica nanoparticles are being investigated for a number of medical applications; however, their use in vivo has been questioned because of the potential for bioaccumulation. To obviate this problem, silica nanoshells were tested for enhanced biodegradability by doping iron(III) into the nanoshells. Exposure of the doped silica to small molecule chelators and mammalian serum was explored to test whether the removal of iron(III) from the silica nanoshell structure would facilitate its degradation. Iron chelators, such as EDTA, desferrioxamine, and deferiprone, were found to cause the nanoshells to degrade on the removal of iron(III) within several days at 80 °C. When the iron(III)-doped, silica nanoshells were submerged in fetal bovine and human serums at physiological temperature, they also degrade via removal of the iron by serum proteins, such as transferrin, over a period of several weeks.
硅纳米颗粒因其在许多医学应用中的潜在价值而备受关注;然而,由于其可能存在生物蓄积性,其在体内的应用受到了质疑。为了解决这个问题,研究人员通过在纳米壳中掺杂铁(III)来提高硅纳米壳的生物降解性。研究人员通过向掺杂铁的硅纳米壳中添加小分子螯合剂和哺乳动物血清来探索是否能够通过去除硅纳米壳结构中的铁(III)来促进其降解。研究发现,EDTA、去铁胺和地拉罗司等铁螯合剂能够在 80°C 下在几天内去除铁(III),从而导致纳米壳降解。当铁(III)掺杂的硅纳米壳在生理温度下浸泡在胎牛血清和人血清中时,通过血清蛋白(如转铁蛋白)在数周内去除铁,纳米壳也会发生降解。